FibroBiologics Inc. Assignment Agreements
5 Contracts & Agreements
- Amendment 2 to the Patent Assignment Agreement between SpinalCyte LLC and FibroBiologics, Inc., effective as of May 17, 2021 (Filed With SEC on August 7, 2024)
- Amendment 1 to the Patent Assignment Agreement, effective August 2, 2022 (Filed With SEC on November 28, 2023)
- Patent Assignment Agreement dated May 17, 2021, between SpinalCyte LLC and FibroBiologics, LLC (Filed With SEC on November 28, 2023)
- Amendment 1 to the Patent Assignment Agreement, effective August 2, 2022 (Filed With SEC on November 7, 2023)
- Patent Assignment Agreement dated May 17, 2021, between SpinalCyte LLC and FibroBiologics, LLC (Filed With SEC on November 7, 2023)
